India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...

A new Mounjaro user has opened up on their experience taking the drug - including the one side effect they're struggling with ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

Weight loss injections could be key to controlling a chronic condition in thousands of Brits, new research suggests ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...

Wegovy, India’s first injectable semaglutide for chronic weight management, recorded Rs 2.54 crore in sales in June ...

A woman who has lost more than three stone while taking Mounjaro has revealed how using the GLP-1 medication has 'ruined' her ...

A small number of people using Mounjaro, Ozempic or Wegovy injections have reported increased skin sensitivity, and a number ...

Women who use an oral contraceptive might want to consider using a back-up method after starting a weight loss drug.

India's weight-loss game is getting serious! The country's anti-obesity market is now worth ₹628 crore, and it's climbing ...

Researchers said the drugs should be explored as a potential treatment for obese people with the respiratory condition, who ...